期刊
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
卷 16, 期 4, 页码 307-313出版社
ELSEVIER
DOI: 10.1016/S1773-2247(06)50055-3
关键词
drug delivery system; nanoparticles; dextran-poly-(epsilon-caprolactone) copolymer; degradation; lipase; dextranase; tamoxifen
This work deals with new poly-epsilon-caprolactone grafted dextran copolymers (Dex-PCL) able to solubilize tamoxifen, a poorly water soluble drug. Micro- and nanoparticles with sizes ranging from 100 to 3,000 nm, composed of Dex-PCL with various Dex contents, were prepared by the nanoprecipitation technique. Structural and surface characterization by dextranase degradation in comparison with the data obtained from the NMR studies proved core-shell structure of these nanoparticles. The PCL core of the Dex-PCL nanoparticles was degraded by the Pseudomonas lipase. Encapsulation of tamoxifen in biodegradable Dex-PCL nanoparticles resulted in loadings as high as 44 wt %. In vitro release studies of tamoxifen performed in phosphate buffer containing 0.5% (w/v) sodium lauryl sulfate showed a sustained release over more than 72 h. This result confirms that most of drug was located in the core of Dex-PCL nanoparticles.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据